Vignette-based study of ovarian cancer screening: Do U.S. physicians report adhering to evidence-based recommendations?

Annals of Internal Medicine

Volumn 156, Issue 3, 2012, Pages 182-194

  Baldwin, Laura Mae ^a   Trivers, Katrina F ^b   Matthews, Barbara ^c   Andrilla, C Holly A ^a   Miller, Jacqueline W ^b   Berry, Donna L ^d   Lishner, Denise M ^a   Goff, Barbara A ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; CROSS-SECTIONAL STUDY; EVIDENCE BASED MEDICINE; FEMALE; HEALTH SURVEY; HUMAN; MALE; OVARY CANCER; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY; UNITED STATES;

EID: 84863078516     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-156-3-201202070-00006     Document Type: Article

References (58)

1. U.S. Preventive Services Task Force. Screening for ovarian cancer, topic page. Rockville, MD: Agency for Healthcare Research and Quality; 2004. Accessed at www.ahrq.gov/clinic/uspstf/uspsovar.htm on 10 June 2010.
2. ACOG Committee on Gynecologic Practice. ACOG Committee Opinion No. 356: routine cancer screening. Obstet Gynecol. 2006;108:1611-3. [PMID: 17138803]
3. Gladstone CQ. Screening for ovarian cancer. In: Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa, Ontario, Canada: Health Canada; 1994:870-81.
4. American Cancer Society. Ovarian cancer. Accessed at www.cancer.org /Cancer/OvarianCancer/DetailedGuide/ovarian-cancer-detection on 22 May 2011.
5. Buys SS, Partridge E, Greene MH, Prorok PC, Reding D, Riley TL, et al; PLCO Project Team. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol. 2005;193:1630-9. [PMID: 16260202]
6. Eichorn J. Study results show ovarian cancer deaths are not reduced by earlydetection screening methods. OncLive. 18 May 2011. Accessed at www.onclive.com /conference-coverage/asco-2011/Study-Results-Show-Ovarian-Cancer-Deaths-Are-Not-Reduced-by-Early-Detection-Screening-Methods on 3 June 2011.
7. Centers for Disease Control and Prevention. National Program of Cancer Registries (NPCR). United States cancer statistics (USCS). 2007 top ten cancers. Accessed at http://apps.nccd.cdc.gov/uscs/toptencancers.aspx on 10 June 2011.
8. National Institutes of Health Consensus Development Conference Statement. Ovarian cancer: screening, treatment, and follow-up. Gynecol Oncol. 1994;55: S4-14. [PMID: 7835809]
9. Fishman DA, Cohen L, Blank SV, Shulman L, Singh D, Bozorgi K, et al. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. Am J Obstet Gynecol. 2005;192:1214-21. [PMID: 15846205]
10. Goff BA, Muntz HG. Screening and early diagnosis of ovarian cancer. Women's Health in Primary Care. 2005;8:262-8.
11. Jacobs I, Davies AP, Bridges J, Stabile I, Fay T, Lower A, et al. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. BMJ. 1993;306:1030-4. [PMID: 8490497]
12. Jacobs IJ, Menon U. Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteomics. 2004;3:355-66. [PMID: 14764655]
13. Liede A, Karlan BY, Baldwin RL, Platt LD, Kuperstein G, Narod SA. Cancer incidence in a population of Jewish women at risk of ovarian cancer. J Clin Oncol. 2002;20:1570-7. [PMID: 11896106]
14. Menon U, Jacobs IJ. Ovarian cancer screening in the general population. Curr Opin Obstet Gynecol. 2001;13:61-4. [PMID: 11176234]
15. Olivier RI, Lubsen-Brandsma MA, Verhoef S, van Beurden M. CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. Gynecol Oncol. 2006;100:20-6. [PMID: 16188302]
16. Paley PJ. Ovarian cancer screening: are we making any progress? Curr Opin Oncol. 2001;13:399-402. [PMID: 11555720]
17. Partridge E, Kreimer AR, Greenlee RT, Williams C, Xu JL, Church TR, et al; PLCO Project Team. Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol. 2009;113:775-82. [PMID: 19305319]
18. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002;359:572-7. [PMID: 11867112]
19. Skates SJ, Horick N, Yu Y, Xu FJ, Berchuck A, Havrilesky LJ, et al. Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colonystimulating factor using mixtures of multivariate normal distributions. J Clin Oncol. 2004;22:4059-66. [PMID: 15381683]
20. van der Velde NM, Mourits MJ, Arts HJ, de Vries J, Leegte BK, Dijkhuis G, et al. Time to stop ovarian cancer screening in BRCA1/2 mutation carriers? Int J Cancer. 2009;124:919-23. [PMID: 19035463]
21. van Nagell JR Jr, DePriest PD, Reedy MB, Gallion HH, Ueland FR, Pavlik EJ, et al. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol. 2000;77:350-6. [PMID: 10831341]
22. Woodward ER, Sleightholme HV, Considine AM, Williamson S, McHugo JM, Cruger DG. Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective. BJOG. 2007;114:1500-9. [PMID: 17903229]
23. Bell R, Petticrew M, Luengo S, Sheldon TA. Screening for ovarian cancer: a systematic review. Health Technol Assess. 1998;2:i-iv, 1-84. [PMID: 9561894]
24. ACOG Committee on Practice Bulletins. Hereditary breast and ovarian cancer syndrome. Gynecol Oncol. 2009;113:6-11. [PMID: 19309638]
25. U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med. 2005;143:355-61. [PMID: 16144894]
26. Schorge JO, Modesitt SC, Coleman RL, Cohn DE, Kauff ND, Duska LR, et al. SGO White Paper on ovarian cancer: etiology, screening and surveillance. Gynecol Oncol. 2010;119:7-17. [PMID: 20692025]
27. MacDonald DJ, Sarna L, Uman GC, Grant M, Weitzel JN. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers. Oncol Nurs Forum. 2006;33:E27-35. [PMID: 16518435]
28. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291:71-8. [PMID: 14709578]
29. Chan EC, Barry MJ, Vernon SW, Ahn C. Brief report: physicians and their personal prostate cancer-screening practices with prostate-specific antigen. A national survey. J Gen Intern Med. 2006;21:257-9. [PMID: 16637825]
30. Fowler FJ Jr, Bin L, Collins MM, Roberts RG, Oesterling JE, Wasson JH, et al. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med. 1998;104:526-32. [PMID: 9674714]
31. Goff BA, Matthews B, Andrilla CH, Miller JW, Trivers KF, Berry D, et al. How are symptoms of ovarian cancer managed? A study of primary care physicians. Cancer. 2011;117:4414-23. [PMID: 21413001]
32. Trivers KF, Baldwin LM, Miller JW, Matthews B, Andrilla CH, Lishner DM, et al. Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: A vignette-based study. Cancer. 2011;117:5334-43. [PMID: 21792861]
33. Dillman DA. Mail and Internet Surveys: The Tailored Design Method. 2nd ed. Hoboken, NJ: J Wiley; 2007.
34. Fishbein M, Ajzen I. Belief, Attitude, Intention, and Behavior: An Introduction to Theory and Research. Reading, MA: Addison-Wesley; 1975.
35. Ajzen I. Perceived behavioral control, self-efficacy, locus of control, and the theory of planned behavior. J Appl Soc Psychol. 2002;32:665-83.
36. Ajzen I. Theory of planned behavior. Accessed at http://people.umass.edu/aizen/tpb.html on 10 June 2011.
37. Katz DA, Williams GC, Brown RL, Aufderheide TP, Bogner M, Rahko PS, et al. Emergency physicians' fear of malpractice in evaluating patients with possible acute cardiac ischemia. Ann Emerg Med. 2005;46:525-33. [PMID: 16308068]
38. Franks P, Williams GC, Zwanziger J, Mooney C, Sorbero M. Why do physicians vary so widely in their referral rates? J Gen Intern Med. 2000;15:163-8. [PMID: 10718896]
39. Morrill R, Cromartie J, Hart LG. Metropolitan, urban, and rural commuting areas: toward a better depiction of the US settlement system. Urban Geography. 1999;20:727-48.
40. Economic Research Service. Measuring rurality: Rural-Urban Commuting Area Codes. Accessed at www.ers.usda.gov/briefing/Rurality/RuralUrbanCommutingAreas / on 11 June 2010.
41. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 103: hereditary breast and ovarian cancer syndrome. Obstet Gynecol. 2009;113:957-66. [PMID: 19305347]
42. Bieler GS, Brown GG, Williams RL, Brogan DJ. Estimating modeladjusted risks, risk differences, and risk ratios from complex survey data. Am J Epidemiol. 2010;171:618-23. [PMID: 20133516]
43. Mehrotra A, Zaslavsky AM, Ayanian JZ. Preventive health examinations and preventive gynecological examinations in the United States. Arch Intern Med. 2007;167:1876-83. [PMID: 17893309]
44. U.S. Census Bureau. The 2012 Statistical Abstract. Population: estimates and projections by age, sex, race/ethnicity. Accessed at www.census.gov/compendia/statab /cats/population/estimates_and_projections_by_age_sex_raceethnicity.html on 7 October 2012.
45. Klein WM, Stefanek ME. Cancer risk elicitation and communication: lessons from the psychology of risk perception. CA Cancer J Clin. 2007;57:147-67. [PMID: 17507441]
46. White DB, Bonham VL, Jenkins J, Stevens N, McBride CM. Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians. Cancer Epidemiol Biomarkers Prev. 2008;17:2980-6. [PMID: 18990739]
47. Wideroff L, Freedman AN, Olson L, Klabunde CN, Davis W, Srinath KP, et al. Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev. 2003;12:295-303. [PMID: 12692103]
48. Sifri R, Myers R, Hyslop T, Turner B, Cocroft J, Rothermel T, et al. Use of cancer susceptibility testing among primary care physicians. Clin Genet. 2003;64:355-60. [PMID: 12974741]
49. Keitz SA, Stechuchak KM, Grambow SC, Koropchak CM, Tulsky JA. Behind closed doors: management of patient expectations in primary care practices. Arch Intern Med. 2007;167:445-52. [PMID: 17353491]
50. Kravitz RL, Bell RA, Azari R, Kelly-Reif S, Krupat E, Thom DH. Direct observation of requests for clinical services in office practice: what do patients want and do they get it? Arch Intern Med. 2003;163:1673-81. [PMID: 12885682]
51. Murray E, Lo B, Pollack L, Donelan K, Lee K. Direct-to-consumer advertising: physicians' views of its effects on quality of care and the doctor-patient relationship. J Am Board Fam Pract. 2003;16:513-24. [PMID: 14963078]
52. Green MJ, Peterson SK, Baker MW, Harper GR, Friedman LC, Rubinstein WS, et al. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. JAMA. 2004;292:442-52. [PMID: 15280342]
53. Pham HH, Schrag D, Hargraves JL, Bach PB. Delivery of preventive services to older adults by primary care physicians. JAMA. 2005;294:473-81. [PMID: 16046654]
54. American Cancer Society. Ovarian cancer: common questions about symptoms and screening. 30 August 2010. Accessed at www.cancer.org/cancer/news /features/ovarian-cancer-why-screening-isnt-routine on 9 June 2011.
55. American Cancer Society. American Cancer Society guidelines for the early detection of cancer. 23 June 2011. Accessed at www.cancer.org/Healthy /FindCancerEarly/CancerScreeningGuidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer on 9 June 2011.
56. Peabody JW, Luck J, Glassman P, Dresselhaus TR, Lee M. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA. 2000;283:1715-22. [PMID: 10755498]
57. Peabody JW, Luck J, Glassman P, Jain S, Hansen J, Spell M, et al. Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med. 2004;141:771-80. [PMID: 15545677]
58. Dresselhaus TR, Peabody JW, Luck J, Bertenthal D. An evaluation of vignettes for predicting variation in the quality of preventive care. J Gen Intern Med. 2004;19:1013-8. [PMID: 15482553]